Comments on cochrane review on direct-acting antivirals for hepatitis C

Affiliations

¹ Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.
² Liver Center and Gastroenterology Division, Massachusetts General Hospital, Boston, MA.
³ Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ.
⁴ Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA.
⁵ Division of Infectious Diseases, Duke University School of Medicine, Durham, NC.
⁶ Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO.

Free article

Anna S Lok et al. Hepatology. 2017 Oct.

Free article

. 2017 Oct;66(4):1016-1019.

doi: 10.1002/hep.29366. Epub 2017 Aug 26.

¹ Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.
² Liver Center and Gastroenterology Division, Massachusetts General Hospital, Boston, MA.
³ Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ.
⁴ Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA.
⁵ Division of Infectious Diseases, Duke University School of Medicine, Durham, NC.
⁶ Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO.

No abstract available

Comment in

Letter to Editor: Response to AASLD Editorial/Message from the President.
Koretz RL, Jakobsen JC, Hauser G, Nikolova D, Gluud C. Koretz RL, et al. Hepatology. 2019 May;69(5):2300. doi: 10.1002/hep.30298. Hepatology. 2019. PMID: 30276829
Reply.
Lok AS, Powderly WG. Lok AS, et al. Hepatology. 2019 May;69(5):2301. doi: 10.1002/hep.30564. Hepatology. 2019. PMID: 30762891